Damandaman, Luza .
HRN: 24-46-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/29/2024
CEFUROXIME 1.5GM (VIAL)
01/29/2024
02/04/2024
IV
1.5 Gm
Q 8h
S/P LSTCS
Waiting Final Action
01/29/2024
CEFUROXIME 500MG (TAB)
01/31/2024
02/06/2024
ORAL
500mg
BID
Sp LTCS
Waiting Final Action